TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR

Yongliang Liu1, Xiangqin Qi2, Zhenan Zhao1

  • 1Department of Otolaryngolgogy, Zibo Central Hospital, Shandong University, Zibo, China.

Insights

Tumour necrosis factor-α-induced protein 8 like-1 (TIPE1) promotes nasopharyngeal carcinoma (NPC) progression by inhibiting autophagy and inducing cell proliferation. TIPE1 may serve as a diagnostic and prognostic biomarker for NPC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumour necrosis factor-α-induced protein 8 like-1 (TIPE1) has varied roles in different cancers.
  • Its function in nasopharyngeal carcinoma (NPC) was previously unknown.

Purpose of the Study:

  • To investigate the role of TIPE1 in nasopharyngeal carcinoma (NPC).
  • To explore the underlying molecular mechanisms of TIPE1 in NPC progression.

Main Methods:

  • Analysis of TIPE1 expression in NPC tissues and its correlation with clinical parameters.
  • In vitro studies using NPC cell lines (CNE-1, CNE-2Z) to assess the effects of TIPE1 on cell proliferation and autophagy.
  • Investigation of the involvement of the AMPK/mTOR signaling pathway.
  • In vivo studies using a mouse model.

Main Results:

  • TIPE1 expression is upregulated in NPC tissues and correlates with increased proliferation (Ki67) and decreased patient survival.
  • TIPE1 overexpression inhibits autophagy and promotes cell proliferation in NPC cells, while TIPE1 knockdown has the opposite effect.
  • TIPE1 influences the AMPK/mTOR pathway by affecting levels of pmTOR, pS6, P62, and pAMPK.
  • TIPE1 promotes tumour growth in vivo.
  • Autophagy inhibition by TIPE1 can be rescued by AICAR, an AMPK activator.

Conclusions:

  • TIPE1 promotes NPC progression by inhibiting autophagy and inducing cell proliferation through the AMPK/mTOR signaling pathway.
  • TIPE1 is a potential diagnostic and prognostic biomarker for NPC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K